TCELX | TRCLX | TCELX / TRCLX | |
Total Expense Ratio | 1.40 | 1.03 | 136% |
Annual Report Gross Expense Ratio | 2.67 | 2.10 | 127% |
Fund Existence | 5 years | 5 years | - |
Gain YTD | 0.465 | 0.473 | 98% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 500000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 40.1M | 40.1M | 100% |
Annual Yield % from dividends | 1.35 | 1.68 | 80% |
Returns for 1 year | 6.38 | 6.63 | 96% |
Returns for 3 years | -10.84 | -9.86 | 110% |
Returns for 5 years | 3.74 | 3.86 | 97% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FSMEX | 56.16 | N/A | N/A |
Fidelity Select Medical Tech and Devcs | |||
MNHIX | 23.81 | N/A | N/A |
Manning & Napier Pro-Blend Max Term I | |||
FLIIX | 11.41 | N/A | N/A |
First Sentier Global Listed Infras I | |||
UIVVX | 11.19 | N/A | N/A |
MFS Intrinsic Value A | |||
OAYEX | 18.97 | -0.02 | -0.11% |
Oakmark International Small Cap Advisor |